WSL
MACK
Western Standard LLC’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,172,513
| Closed | -$32.1M | – | 31 |
|
|
2024
Q1 | $32.1M | Hold |
2,172,513
| – | – | 15.37% | 1 |
|
|
2023
Q4 | $29.1M | Buy |
2,172,513
+278,500
| +15% | +$3.73M | 19.4% | 1 |
|
|
2023
Q3 | $23.4M | Buy |
1,894,013
+221,550
| +13% | +$2.73M | 21.09% | 1 |
|
|
2023
Q2 | $20.6M | Hold |
1,672,463
| – | – | 17.72% | 1 |
|
|
2023
Q1 | $20.6M | Buy |
1,672,463
+142,969
| +9% | +$1.76M | 20.85% | 1 |
|
|
2022
Q4 | $17.5M | Buy |
1,529,494
+357,031
| +30% | +$4.09M | 15.43% | 1 |
|
|
2022
Q3 | $4.4M | Sell |
1,172,463
-97,095
| -8% | -$364K | 5.03% | 8 |
|
|
2022
Q2 | $7.55M | Buy |
1,269,558
+97,095
| +8% | +$578K | 5.73% | 4 |
|
|
2022
Q1 | $6.8M | Hold |
1,172,463
| – | – | 6.46% | 5 |
|
|
2021
Q4 | $4.58M | Sell |
1,172,463
-97,095
| -8% | -$380K | 2.71% | 11 |
|
|
2021
Q3 | $6.13M | Hold |
1,269,558
| – | – | 3.49% | 7 |
|
|
2021
Q2 | $8.11M | Buy |
1,269,558
+257,987
| +26% | +$1.65M | 4.77% | 5 |
|
|
2021
Q1 | $6.35M | Hold |
1,011,571
| – | – | 4.53% | 5 |
|
|
2020
Q4 | $6.97M | Sell |
1,011,571
-51,696
| -5% | -$356K | 7.97% | 1 |
|
|
2020
Q3 | $4.25M | Buy |
1,063,267
+193,913
| +22% | +$776K | 4.83% | 8 |
|
|
2020
Q2 | $2.9M | Buy |
869,354
+26,441
| +3% | +$88.1K | 3.47% | 12 |
|
|
2020
Q1 | $1.81M | Hold |
842,913
| – | – | 1.67% | 18 |
|
|
2019
Q4 | $2.66M | Hold |
842,913
| – | – | 2.07% | 17 |
|
|
2019
Q3 | $3.79M | Buy |
842,913
+218,157
| +35% | +$982K | 3% | 12 |
|
|
2019
Q2 | $3.78M | Buy |
624,756
+199,397
| +47% | +$1.21M | 2.79% | 13 |
|
|
2019
Q1 | $2.96M | Buy |
425,359
+274,996
| +183% | +$1.91M | 2.62% | 11 |
|
|
2018
Q4 | $580K | Buy |
+150,363
| New | +$580K | 0.54% | 35 |
|